Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Yumuk, P. F. [1 ]
Teomete, M. [1 ]
Dane, F. [1 ]
Cabuk, D. [1 ]
Basaran, G. [1 ]
Turhal, N. S. [1 ]
机构：
[1] Marmara Univ, Med Sch Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19055
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Ukena, D
    Berg, M
    Leutz, M
    Zell, L
    Schlimmer, P
    Sybrecht, GW
    LUNG CANCER, 1998, 19 (01) : 31 - 36
  • [22] Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)
    Bradford, D. S.
    Socinski, M. A.
    LaRocca, R. V.
    Hensing, T. A.
    Bordoni, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Subjective Global Assessment as an independent predictor of survival in patients with stage IIIB and IV non-small cell lung cancer
    Lammersfeld, C.
    Gupta, D.
    Dahlk, S.
    Vashi, P. G.
    Aslam, A.
    Lis, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Gemcitabine plus cisplatin in patients with state IIIB/IV non-small cell lung cancer (NSCLC)
    Teixeira, Encarnacao
    Goncalves, Ines
    Mayor, Renato Sotto
    Melo, Ricardo
    Lopes, Carlos
    Pinto, Ana
    ANNALS OF ONCOLOGY, 2004, 15 : 194 - 194
  • [25] The multimodality therapy for patients with advanced non-small cell lung cancer (stage IIIB and IV).
    Guo, H
    Li, Z
    Cheng, H
    Sun, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 707S - 707S
  • [26] Upcoming strategies in the treatment of non-small cell lung cancer stage IIIB/wet and IV
    Zabernigg, August
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2007, 157 (21-22) : 536 - 539
  • [27] Treatment Initiation, Tolerance and Survival in Elderly Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Helfrich, G.
    Gijtenbeek, R. G.
    Venmans, B. J.
    Ten Brinke, A.
    De Jong, K.
    van Geffen, W. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [28] Efficacy of Icotinib treatment in patients with stage IIIb/IV non-small cell lung cancer
    Qin, Na
    Yang, Xinjie
    Zhang, Quan
    Li, Xi
    Zhang, Hui
    Lv, Jialin
    Wu, Yuhua
    Wang, Jinghui
    Zhang, Shucai
    THORACIC CANCER, 2014, 5 (03) : 243 - 249
  • [29] Impact of Accompanying Comorbidities on Survival in Patients with Stage IIIB- IV Non-Small-Cell Lung Cancer
    Demirpence, Mustafa
    Akman, Tulay
    Oztop, Ilhan
    Unek, Ilkay T.
    Yavuzsen, Tugba
    Yilmaz, Ahmet U.
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (04): : 223 - 232
  • [30] Role for surgical resection in the multidisciplinary treatment of stage IIIB non-small cell lung cancer (NSCLC).
    Bott, Matthew
    Patel, Aalok
    Crabtree, Traves
    Morgensztern, Daniel
    Robinson, Cliff Grant
    Colditz, Graham A.
    Waqar, Saiama Naheed
    Kreisel, Daniel
    Krupnick, Alexander Sasha
    Patterson, G. Alexander
    Broderick, Stephen R.
    Meyers, Bryan F.
    Puri, Varun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345